Myocardial Ischemia Induces SDF-1α Release in Cardiac Surgery Patients

J Cardiovasc Transl Res. 2016 Jun;9(3):230-238. doi: 10.1007/s12265-016-9689-x. Epub 2016 Apr 7.

Abstract

In the present observational study, we measured serum levels of the chemokine stromal cell-derived factor-1α (SDF-1α) in 100 patients undergoing cardiac surgery with cardiopulmonary bypass at seven distinct time points including preoperative values, myocardial ischemia, reperfusion, and the postoperative course. Myocardial ischemia triggered a marked increase of SDF-1α serum levels whereas cardiac reperfusion had no significant influence. Perioperative SDF-1α serum levels were influenced by patients' characteristics (e.g., age, gender, aspirin intake). In an explorative analysis, we observed an inverse association between SDF-1α serum levels and the incidence of organ dysfunction. In conclusion, time of myocardial ischemia was identified as the key stimulus for a significant upregulation of SDF-1α, indicating its role as a marker of myocardial injury. The inverse association between SDF-1α levels and organ dysfunction association encourages further studies to evaluate its organoprotective properties in cardiac surgery patients.

Keywords: Coronary disease; Inflammation; Ischemia; Reperfusion; Stromal cell-derived factor 1 alpha (SDF-1α).

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / blood
  • Cell Hypoxia
  • Cells, Cultured
  • Chemokine CXCL12 / blood*
  • Coronary Artery Bypass / adverse effects*
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / surgery*
  • Female
  • Heart Valve Diseases / blood
  • Heart Valve Diseases / diagnosis
  • Heart Valve Diseases / surgery*
  • Heart Valve Prosthesis Implantation / adverse effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Male
  • Middle Aged
  • Myocardial Reperfusion Injury / blood*
  • Myocardial Reperfusion Injury / diagnosis
  • Myocardial Reperfusion Injury / etiology
  • Predictive Value of Tests
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • CXCL12 protein, human
  • Chemokine CXCL12